Skip to main content
Contact Us
Subscribe
E-Edition
85°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Renovaro Inc. - Common Stock
(NQ:
RENB
)
0.4713
-0.0487 (-9.37%)
Streaming Delayed Price
Updated: 3:41 PM EDT, Apr 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Renovaro Inc. - Common Stock
< Previous
1
2
3
4
Next >
Milestone Merger Payment made with Predictive Oncology to Advance AI-Driven Biomarker Discovery and Precision Medicine in Cancer and Beyond: Renovaro, Inc. (NASDAQ: RENB)
March 03, 2025
Via
Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
March 03, 2025
From
Renovaro Inc
Via
GlobeNewswire
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences
March 03, 2025
From
Predictive Oncology Inc.
Via
GlobeNewswire
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
February 26, 2025
From
Renovaro Inc
Via
GlobeNewswire
Renovaro Announces $15 million in Equity Committed
February 26, 2025
From
Renovaro Inc
Via
GlobeNewswire
Renovaro Appoints Nathen Fuentes as Chief Financial Officer
January 07, 2025
From
Renovaro Inc
Via
GlobeNewswire
Renovaro Issues Shareholder Letter and Provides Corporate Update
January 07, 2025
From
Renovaro Inc
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Predictive Oncology Inc. (Nasdaq - POAI), SunLink Health Systems, Inc. (NYSE American - SSY), Universal Stainless & Alloy Products, Inc. (Nasdaq - USAP), Patterson
January 06, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
January 06, 2025
From
Renovaro Inc
Via
GlobeNewswire
Predictive Oncology Announces Agreement to be Acquired by Renovaro
January 06, 2025
From
Predictive Oncology Inc.
Via
GlobeNewswire
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
December 30, 2024
From
Renovaro Inc
Via
GlobeNewswire
RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program
December 23, 2024
From
Renovaro Inc
Via
GlobeNewswire
Renovaro Regains Compliance with NASDAQ Listing Requirement
December 20, 2024
From
Renovaro Inc
Via
GlobeNewswire
Strategic Collaboration with Nebul to Employ NVIDIA Cutting Edge AI Tech with Established GEDi CUBE as a Paradigm Shift for Early Disease Detection: Renovaro, Inc. (Nasdaq: RENB)
December 20, 2024
Via
Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection
December 20, 2024
From
Renovaro Inc
Via
GlobeNewswire
Renovaro Issues Shareholder Letter and Provides Corporate Update
November 04, 2024
From
Renovaro Inc
Via
GlobeNewswire
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
October 17, 2024
From
Renovaro Inc
Via
GlobeNewswire
Powerful Leadership Transition to Optimize Highly Promising AI Platform, RenovaroCube for Multi-Cancer Early Detection and Patient Monitoring: Renovaro, Inc. (Nasdaq: RENB)
October 16, 2024
Via
Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Renovaro Announces Strategic Restructuring and Leadership Transition
October 16, 2024
From
Renovaro Inc
Via
GlobeNewswire
PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics
September 19, 2024
Strategic partnership aims to further develop Cube’s award-winning AI guided platform for Software as a Service (SaaS) for the private sector and large healthcare systems and diagnostic to support...
From
Renovaro Inc
Via
GlobeNewswire
Specialist AI Team from “PersonalAIze” Highlights the Strength, Potential and Visionary Talent Behind Software as a Service (SaaS) Platform for Early Cancer Detection: Renovaro, Inc. (Nasdaq: RENB)
September 17, 2024
Via
Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
September 17, 2024
Assessment by specialist AI team from “PersonalAIze” Highlights the Strength, Potential, and Visionary Talent Behind the Innovative Software as a Service (SaaS) Platform
From
Renovaro Inc
Via
GlobeNewswire
RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
September 13, 2024
From
Renovaro Inc
Via
GlobeNewswire
RenovaroCube Announces Strategic Offering of Up to 20% Ownership
September 11, 2024
From
Renovaro Inc
Via
GlobeNewswire
Renovaro, Inc. Announces $10 million in Equity Committed
June 14, 2024
From
Renovaro Inc
Via
GlobeNewswire
Impressive Short Squeeze Triggered for Cancer Immunotherapy Company Renovaro, Inc. (NASDAQ: RENB)
June 10, 2024
Via
Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
May 24, 2024
From
Renovaro Inc
Via
GlobeNewswire
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
May 24, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:RENB),(NASDAQ:CYTO),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Launch of Groundbreaking Cancer Detection Platform Flamingo with Nvidia AI Computing Power, Plus Plans to Acquire 100% Ownership of Cyclomics: Renovaro Inc. (Nasdaq: RENB)
April 30, 2024
Via
Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
May 24, 2024
From
FN Media Group LLC
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
